News FDA Approves Revolution Medicines’ Rasonque, First RAS(ON) Inhibitor for Metastatic Pancreatic Cancer pharminent August 26, 2026
News FDA Approves J&J’s Imaavy for Warm Autoimmune Hemolytic Anemia, the First Therapy Ever Cleared in the Disease pharminent August 25, 2026
M&A / Deals China’s Haisco forms immunology biotech with up to $1.5B from American VCs pharminent August 25, 2026
Pipeline Bausch + Lomb advances dry eye disease drug to Phase 3 despite mid-stage fail pharminent August 25, 2026
Regulatory FDA places clinical hold on Regenxbio’s RGX-121 in MPS II trial pharminent August 25, 2026
News Genentech Licenses Hanmi’s Muscle-Sparing Obesity Drug in Deal Worth Up to $2.3 Billion pharminent August 24, 2026
M&A / Deals Roche commits to lean-mass preservation with Hanmi obesity deal pharminent August 24, 2026
News Johnson & Johnson Wins EU Approval for Tecvayli-Daratumumab in Second-Line Myeloma pharminent August 21, 2026
Clinical Data Novo Nordisk starts trialing lower maintenance doses of oral Wegovy pharminent August 21, 2026
News Regeneron’s Pasatru Wins Full FDA Approval for Ultra-Rare ‘Stone Man Disease’ pharminent August 20, 2026
Regulatory Ultragenyx wins FDA approval for first treatment targeting root cause of GSDIa pharminent August 20, 2026
Regulatory Regeneron wins FDA approval to challenge Ipsen for rare bone disease market pharminent August 20, 2026
Clinical Data Merck’s Moderna-partnered vaccine success clears view of post-Keytruda future pharminent August 20, 2026
Regulatory FDA grants accelerated approval to Ultragenyx’s Genglycos gene therapy pharminent August 20, 2026
News Moderna and Merck’s Personalized Melanoma Vaccine Scores Historic Phase 3 Win pharminent August 19, 2026
M&A / Deals BioMarin spends up to $490m for Alesta’s bone disease candidate pharminent August 19, 2026
News Amylyx’s Avexitide Succeeds in Phase 3 Pivotal Study for Post-Bariatric Hypoglycemia pharminent August 18, 2026
News AstraZeneca Claims Dual Lung Cancer Phase 3 Wins, but Bispecific Failure Steals the Headline pharminent August 17, 2026
M&A / Deals Novo Nordisk and AWS form AI partnership to speed drug discovery pharminent August 17, 2026
Regulatory Lantheus Holdings’ Alzheimer’s radiodiagnostic secures FDA approval pharminent August 17, 2026
News BMS Wins First FDA Approval for CELMoD Class With Zenbexus in Multiple Myeloma pharminent August 14, 2026
Policy / Pricing Prior Authorization Metrics Provide New Insights into Insurer Practices, but Gaps Remain pharminent August 13, 2026
News Eli Lilly Files Six Lawsuits to Combat Illegal Retatrutide Black Market pharminent August 12, 2026
M&A / Deals Sentynl bets up to $475M in licensing deal for Mereo’s rare lung disease asset pharminent August 12, 2026
News Trump Executive Order Strips Seven Vaccines From Childhood Immunization Recommendations pharminent August 11, 2026
